These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12884185)

  • 21. Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.
    Mancino P; Ucciferri C; Falasca K; Pizzigallo E; Vecchiet J
    Scand J Infect Dis; 2008; 40(1):67-73. PubMed ID: 17852941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Corne P; Marchandin H; Macia JC; Jonquet O
    Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
    Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
    Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
    Brickner SJ; Barbachyn MR; Hutchinson DK; Manninen PR
    J Med Chem; 2008 Apr; 51(7):1981-90. PubMed ID: 18338841
    [No Abstract]   [Full Text] [Related]  

  • 25. First report of Listeria monocytogenes endocarditis treated with linezolid.
    Muñoz P; Ferreira L; Marín M; Rodríguez-Créixems M; Bouza E; García-Fernandez MA;
    Int J Antimicrob Agents; 2006 Nov; 28(5):480-1. PubMed ID: 17008067
    [No Abstract]   [Full Text] [Related]  

  • 26. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis.
    Bailey EM; Faber MD; Nafziger DA
    Am J Kidney Dis; 2001 Oct; 38(4):E20. PubMed ID: 11576907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid for the treatment of adults with bone and joint infections.
    Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ
    Int J Antimicrob Agents; 2007 Mar; 29(3):233-9. PubMed ID: 17204407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.
    Athanassopoulos G; Pefanis A; Sakka V; Iliopoulos D; Perrea D; Giamarellou H
    Antimicrob Agents Chemother; 2006 Feb; 50(2):654-7. PubMed ID: 16436723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid for endocarditis: a case series of 14 patients.
    Tascini C; Bongiorni MG; Doria R; Polidori M; Iapoce R; Fondelli S; Tagliaferri E; Soldati E; Di Paolo A; Leonildi A; Menichetti F
    J Antimicrob Chemother; 2011 Mar; 66(3):679-82. PubMed ID: 21393234
    [No Abstract]   [Full Text] [Related]  

  • 30. Linezolid resistant enterococcus faecium.
    McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
    Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
    [No Abstract]   [Full Text] [Related]  

  • 31. [Linezolid in the treatment of gram positive coccal infections in critical patients].
    Alvarez-Lerma F
    Rev Esp Quimioter; 2010 Mar; 23(1):1-3. PubMed ID: 20232017
    [No Abstract]   [Full Text] [Related]  

  • 32. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
    Bodmann KF
    Pharm Unserer Zeit; 2004; 33(1):38-41. PubMed ID: 14968711
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our experience with linesolid usage in newborn children].
    Atanasova V; Slavkova N; Rosmanova R
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.
    Ang JY; Lua JL; Turner DR; Asmar BI
    Pediatr Infect Dis J; 2003 Dec; 22(12):1101-3. PubMed ID: 14688576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M; Nathwani D; Dryden M
    J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Linezolid, the first oxazolidinone antibiotic].
    Dutronc H; Bocquentin F; Galpérine T; Lafarie-Castet S; Dupon M
    Med Mal Infect; 2005 Sep; 35(9):427-34. PubMed ID: 16297585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterococcal bacteremia complicating pemphigus vulgaris: successful treatment with linezolid.
    Garg G; Thami GP
    J Dermatol; 2004 Jul; 31(7):580-1. PubMed ID: 15492427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.